swish30

DVAX - Potential continuation play intraday

Long
NASDAQ:DVAX   Dynavax Technologies Corporation
Advisory committee has voted in favour of Hepatitis-B vaccine. Now just waiting for FDA approval expected no later than November 10.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.